Mira Pharmaceuticals (MIRA) Other Working Capital Changes (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Other Working Capital Changes of -$33789.0 for Q4 2025, down 109.13% sequentially from $369999.0 in Q3 2025, and down 6.11% YoY from -$35989.6 in Q4 2024.
Mira Pharmaceuticals (MIRA) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Other Working Capital Changes data on file, last reported at -$33789.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 6.11% year-over-year to -$33789.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$17957.0 (up 90.5% YoY) and the FY2025 annual result came in at $429999.0, up 59.92% from the prior year.
- Other Working Capital Changes eased to -$33789.0 in Q4 2025 per MIRA's latest filing, from $369999.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $369999.0 in Q3 2025, with the low at -$76714.0 in Q2 2024.
- Average Other Working Capital Changes over 4 years is $33900.7, with a median of -$17507.0 recorded in 2023.
- Year-over-year, Other Working Capital Changes jumped 7547.57% in 2023 and sank 338.19% in 2024.
- Mira Pharmaceuticals' Other Working Capital Changes stood at $2096.0 in 2022, then jumped by 1855.39% to $40985.0 in 2023, then tumbled by 177.69% to -$31842.0 in 2024, then fell by 6.11% to -$33789.0 in 2025.
- Business Quant data shows MIRA's Other Working Capital Changes at -$33789.0 in Q4 2025, $369999.0 in Q3 2025, and -$56210.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33,789.00 |
| Dec 31, 2025 | -33,789.00 |
| Dec 31, 2025 | -33,789.00 |
| Sep 30, 2025 | 369,999.00 |
| Sep 30, 2025 | 369,999.00 |
| Sep 30, 2025 | 369,999.00 |
| Jun 30, 2025 | -56,210.00 |
| Jun 30, 2025 | -56,210.00 |
| Jun 30, 2025 | -56,210.00 |
| Mar 31, 2025 | 103,884.00 |
| Mar 31, 2025 | 103,884.00 |
| Mar 31, 2025 | 103,884.00 |
| Dec 31, 2024 | -31,842.00 |
| Dec 31, 2024 | -31,842.00 |
| Dec 31, 2024 | -31,842.00 |
| Sep 30, 2024 | -22,051.00 |
| Sep 30, 2024 | -22,051.00 |
| Sep 30, 2024 | -22,051.00 |
| Jun 30, 2024 | -76,714.00 |
| Jun 30, 2024 | -76,714.00 |